|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
/
and Y/
T cells in renal ischemia reperfusion injury
1 Clinical Division of Nephrology, Medical University Innsbruck, Innsbruck, Austria
2 Clinical Division of General Medicine, Medical University Innsbruck, Innsbruck, Austria
* To whom correspondence should be addressed. E-mail: alexander.rosenkranz{at}i-med.ac.at.
T-cells have been implicated in the pathogenesis of renal ischemia reperfusion injury (IRI). To date existing data about the role of the T-cell receptor (Tcr) are contradictory. We hypothesize that the Tcr plays a prominent role in the late phase of renal IRI. Therefore, renal IRI was induced in
/
, Y/
T-cell-deficient and wild-type mice by clamping renal pedicles for 30 min and reperfusing for 24, 48, 72 and 120 hours. Serum-creatinine increased equally in all three groups 24 hours after ischemia, but significantly improved in Tcr-deficient animals compared to wild-type controls after 72 hours. A significant reduction in renal tubular injury and infiltration of CD4+ T-cells in both Tcr-deficient mice compared to wild-type controls was detected. Infiltration of
/
T-cells into the kidney was reduced in Y/
T-cell-deficient mice until 72 hours after ischemia. In contrast, Y/
T-cell infiltration was equal in wild-type and
/
T-cell-deficient mice, suggesting an interaction between
/
and Y/
T-cells. Data of Y/
T-cell deficient mice were confirmed by in vivo depletion of Y/
T-cells in C57BL/6 mice. Whereas
/
T-cell-deficient mice were still protected after 120 hours, Y/
T-cell deficient mice showed a "delayed wild-type phenotype" with a dramatic increase in kidney infiltrating
/
Tcr-expressing, CD4+ T-cells. This report provides further evidence that
/
T-cells are major effector cells in renal IRI, whereas Y/
T-cells play a role as mediator cells in the first 72 hours of renal IRI.
This article has been cited by other articles:
![]() |
J. M. Huber, A. Tagwerker, D. Heininger, G. Mayer, A. R. Rosenkranz, and K. Eller The proteasome inhibitor Bortezomib aggravates renal ischemia-reperfusion injury Am J Physiol Renal Physiol, August 1, 2009; 297(2): F451 - F460. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Kuboki, N. Sakai, J. Tschop, M. J. Edwards, A. B. Lentsch, and C. C. Caldwell Distinct contributions of CD4+ T cell subsets in hepatic ischemia/reperfusion injury Am J Physiol Gastrointest Liver Physiol, May 1, 2009; 296(5): G1054 - G1059. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| Visit Other APS Journals Online |